82 related articles for article (PubMed ID: 7627954)
1. Point mutation of ornithine decarboxylase gene in human hepatocellular carcinoma.
Tamori A; Nishiguchi S; Kuroki T; Koh N; Kobayashi K; Yano Y; Otani S
Cancer Res; 1995 Aug; 55(16):3500-3. PubMed ID: 7627954
[TBL] [Abstract][Full Text] [Related]
2. Relationship between ornithine decarboxylase gene abnormalities and human hepatocarcinogenesis.
Koh N; Tamori A; Nishiguchi S; Kuroki T; Seki S; Kobayashi K; Tanaka T; Kinoshita H; Yano Y; Otani S
Hepatogastroenterology; 1999; 46(26):1100-5. PubMed ID: 10370674
[TBL] [Abstract][Full Text] [Related]
3. Detection of ornithine decarboxylase messenger RNA in human hepatocellular carcinoma by in situ hybridization.
Gan FY; Gesell MS; Moshier JA; Alousi M; Luk GD
Epithelial Cell Biol; 1992 Jan; 1(1):13-7. PubMed ID: 1339180
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of the ornithine decarboxylase gene in human colorectal cancers.
Matsubara N; Yoshitaka T; Hanafusa H; Tanaka N; Shimizu K
J Exp Clin Cancer Res; 2002 Jun; 21(2):191-5. PubMed ID: 12148577
[TBL] [Abstract][Full Text] [Related]
6. Increased translation efficiency and antizyme-dependent stabilization of ornithine decarboxylase in amino acid-supplemented human colon adenocarcinoma cells, Caco-2.
Chabanon H; Persson L; Wallace HM; Ferrara M; Brachet P
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):401-8. PubMed ID: 10816435
[TBL] [Abstract][Full Text] [Related]
7. Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma.
Tamori A; Nishiguchi S; Kuroki T; Seki S; Kobayashi K; Kinoshita H; Otani S
Hepatology; 1994 Nov; 20(5):1179-86. PubMed ID: 7927250
[TBL] [Abstract][Full Text] [Related]
8. Expression of a novel human ornithine decarboxylase-like protein in the central nervous system and testes.
Pitkänen LT; Heiskala M; Andersson LC
Biochem Biophys Res Commun; 2001 Oct; 287(5):1051-7. PubMed ID: 11587527
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin.
Wolf C; Brüss M; Hänisch B; Göthert M; von Kügelgen I; Molderings GJ
Mol Pharmacol; 2007 Jan; 71(1):276-83. PubMed ID: 17047095
[TBL] [Abstract][Full Text] [Related]
10. Expression of arginine decarboxylase and ornithine decarboxylase genes in apple cells and stressed shoots.
Hao YJ; Kitashiba H; Honda C; Nada K; Moriguchi T
J Exp Bot; 2005 Apr; 56(414):1105-15. PubMed ID: 15723827
[TBL] [Abstract][Full Text] [Related]
11. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
Nilsson J; Grahn B; Heby O
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
[TBL] [Abstract][Full Text] [Related]
12. Single amino-acid replacement is responsible for the stabilization of ornithine decarboxylase in HMOA cells.
Miyazaki Y; Matsufuji S; Murakami Y; Hayashi S
Eur J Biochem; 1993 Jun; 214(3):837-44. PubMed ID: 8319692
[TBL] [Abstract][Full Text] [Related]
13. Reduction of ornithine decarboxylase antizyme (ODC-Az) level in the 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model.
Tsuji T; Todd R; Meyer C; McBride J; Liao PH; Huang MF; Chou MY; Donoff RB; Wong DT
Oncogene; 1998 Jul; 16(26):3379-85. PubMed ID: 9692545
[TBL] [Abstract][Full Text] [Related]
14. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
15. Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated.
Gritli-Linde A; Nilsson J; Bohlooly-Y M; Heby O; Linde A
Dev Dyn; 2001 Mar; 220(3):259-75. PubMed ID: 11241834
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells.
Matteucci E; Castoldi R; Desiderio MA
J Cell Physiol; 2001 Mar; 186(3):387-96. PubMed ID: 11169978
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the proteasome and antizyme in ornithine decarboxylase degradation by a reticulocyte lysate.
Murakami Y; Matsufuji S; Tanaka K; Ichihara A; Hayashi S
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):305-8. PubMed ID: 8216232
[TBL] [Abstract][Full Text] [Related]
18. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation.
Shantz LM; Coleman CS; Pegg AE
Cancer Res; 1996 Nov; 56(22):5136-40. PubMed ID: 8912847
[TBL] [Abstract][Full Text] [Related]
19. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
[TBL] [Abstract][Full Text] [Related]
20. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
Voskas D; Mader R; Lee J; Hurta RA
Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
